NRX Pharmaceuticals
NRXP
NRXP
22 hedge funds and large institutions have $4.6M invested in NRX Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
7
Calls
$310K
Puts
$6K
Net Calls
+$304K
Net Calls Change
+$265K
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$2.04M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$305K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$183K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$124K |
| 5 |
Two Sigma Investments
New York
|
+$61.8K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$181K |
| 2 |
Millennium Management
New York
|
-$60.8K |
| 3 |
Squarepoint
New York
|
-$55.7K |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$45.6K |
| 5 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
-$33K |
